A 62-year-old with HFrEF (EF 30%) on furosemide and metoprolol presents for optimization. According to current guidance, which foundational therapy se...

Question

A 62-year-old with HFrEF (EF 30%) on furosemide and metoprolol presents for optimization. According to current guidance, which foundational therapy set improves mortality?

Accepted Answer

ARNI (sacubitril/valsartan), evidence-based beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitor

Answer

ACE inhibitor alone at target dose

Answer

Digoxin and loop diuretic

Answer

Nitrate and hydralazine for all patients regardless of race

Answer

Non-dihydropyridine calcium channel blocker and diuretic

us-abfm MCQ (SBA): Heart Failure

A 62-year-old with HFrEF (EF 30%) on furosemide and metoprolol presents for optimization. According to current guidance, which foundational therapy set improves mortality?